XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Investments and Equity Method Investments (Tables)
 9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Investments and Equity Method Investments
Investments and equity method investments consisted of the following (in thousands):
 As of September 30,As of December 31,
 20232022
Investments:  
Genomatica, Inc. preferred stock$11,885 $44,885 
Synlogic, Inc. common stock1,188 4,819 
Synlogic, Inc. warrants477 1,937 
Marketable equity securities18,960 20,895 
Non-marketable equity securities27,631 17,544 
SAFEs24,829 22,108 
Total$84,970 $112,188 
Equity method investments (1):
  
BiomEdit, LLC$— $369 
Other1,120 1,174 
Total$1,120 $1,543 
(1)Equity method investments in Platform Ventures with a carrying value of zero as of September 30, 2023 and December 31, 2022 were excluded from the table.
(Losses) gains on investments and equity method investments consisted of the following (in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
(Loss) gain on investments:
Synlogic, Inc. common stock$(1,538)$(1,268)$(3,631)$(9,321)
Synlogic, Inc. warrants(618)(510)(1,459)(3,746)
Genomatica, Inc.(33,000)— (33,000)(10,115)
Marketable equity securities460 215 (3,286)(16,604)
Non-marketable equity securities(1,628)(195)(1,628)(195)
SAFEs— — (1,811)— 
Total$(36,324)$(1,758)$(44,815)$(39,981)
Loss on equity method investments:
Joyn Bio, LLC$— $(5,226)$— $(15,637)
Verb Biotics, LLC— — — (15,900)
BiomEdit, LLC— (1,308)(1,462)(5,860)
Ayana, LLC— (15,989)— (15,989)
Other— (188)(54)(378)
Total$— $(22,711)$(1,516)$(53,764)